Insights

Strategic Partnership AccuGenomics recently announced a strategic partnership with LGC Clinical Diagnostics to develop NGS quality control materials. This collaboration validates the SNAQ-SEQ QC standard and provides access to LGC's global diagnostics channels, increasing credibility and potential customer reach for labs adopting NGS QC materials. Sales opportunities include co-selling with LGC and pursuing labs in North America and Europe that need validated QC controls, supported by joint pilot programs.

MRD Growth The SNAQ-SEQ QC technology enhances sensitivity and specificity for low-level targets like ctDNA MRD, addressing assay limit of detection challenges. This creates a compelling value proposition for oncology labs and hospitals performing MRD monitoring and early detection panels, with the option to cross-sell across AccuGenomics’ existing product lines (Myeloid, CRC/NSCLC, TP53, Breast Cancer) by bundling QC standards with tumor panels.

Broad QC Portfolio AccuGenomics offers internal standard mixtures, custom blends, pathogen testing QC, and QC solutions for biomanufacturing (AAV and adventitious agents). This breadth enables multi-product sales to clinical laboratories, CROs, and biopharma manufacturers needing standardized QC across assays; opportunities include tiered offerings, volume pricing, and co-development deals.

Agile Engagements With a lean team of 2-10 employees, AccuGenomics can provide rapid onboarding and customized support, appealing to labs seeking quick deployment of QC materials and validation data. Focus on early-adopter labs and small to mid-size diagnostic developers, pursuing short-cycle pilots, flexible pricing, and dedicated customer success to secure initial contracts.

IP & Global Access A USPTO patent and a global partnership with LGC position AccuGenomics as a protected, scalable supplier of NGS QC materials. This can attract multinational labs and contract manufacturers seeking compliant QC solutions with proven IP protection; pursue distribution partnerships and licensing deals through LGC and other distributors to expand geographic reach.

AccuGenomics Tech Stack

AccuGenomics uses 8 technology products and services including Open Graph, Twemoji, Google Fonts API, and more. Explore AccuGenomics's tech stack below.

  • Open Graph
    Content Management System
  • Twemoji
    Font Scripts
  • Google Fonts API
    Font Scripts
  • jQuery Mobile
    Mobile Frameworks
  • Yoast SEO
    Search Engines
  • X-Content-Type-Options
    Web & Portal Technology
  • MailChimp for WordPress
    Web Platform Extensions
  • Magnific Popup
    Web Tools And Plugins

AccuGenomics's Email Address Formats

AccuGenomics uses at least 1 format(s):
AccuGenomics Email FormatsExamplePercentage
FLast@accugenomics.comJDoe@accugenomics.com
100%

Frequently Asked Questions

Where is AccuGenomics's headquarters located?

Minus sign iconPlus sign icon
AccuGenomics's main headquarters is located at 1410 Commonwealth Drive Suite 105 Wilmington, North Carolina 28403 United States. The company has employees across 1 continents, including North America.

What is AccuGenomics's phone number?

Minus sign iconPlus sign icon
You can contact AccuGenomics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is AccuGenomics's official website and social media links?

Minus sign iconPlus sign icon
AccuGenomics's official website is accugenomics.com and has social profiles on LinkedIn.

What is AccuGenomics's SIC code NAICS code?

Minus sign iconPlus sign icon
AccuGenomics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AccuGenomics have currently?

Minus sign iconPlus sign icon
As of June 2026, AccuGenomics has approximately 7 employees across 1 continents, including North America. Key team members include President: N. L.Svp Business Development & Commercial: D. D.Scientist / Laboratory Manager: B. A.. Explore AccuGenomics's employee directory with LeadIQ.

What industry does AccuGenomics belong to?

Minus sign iconPlus sign icon
AccuGenomics operates in the Biotechnology Research industry.

What technology does AccuGenomics use?

Minus sign iconPlus sign icon
AccuGenomics's tech stack includes Open GraphTwemojiGoogle Fonts APIjQuery MobileYoast SEOX-Content-Type-OptionsMailChimp for WordPressMagnific Popup.

What is AccuGenomics's email format?

Minus sign iconPlus sign icon
AccuGenomics's email format typically follows the pattern of FLast@accugenomics.com. Find more AccuGenomics email formats with LeadIQ.
AccuGenomics logo

AccuGenomics

Biotechnology ResearchNorth Carolina, United States2-10 Employees

AccuGenomics is a biotechnology research company that develops life science tools to improve the accuracy of next-generation sequencing in precision medicine. Its core offering, SNAQ-SEQ, is an internal quality control standard designed to be integrated into existing NGS workflows, enhancing sensitivity and specificity for diagnostics and monitoring, especially at low detection limits. This helps reduce inaccuracies in NGS results that can affect clinical decisions in areas like early detection and measurable residual disease. The company offers multiple products across oncology targets such as myeloid, CRC/NSCLC, ctDNA MRD, TP53, and breast cancer, plus custom internal standard mixtures, and it also supplies standards for pathogen testing and biomanufacturing QC. Based in Wilmington, North Carolina, AccuGenomics announced a strategic partnership with LGC Clinical Diagnostics in 2024 to develop NGS quality control materials.

Section iconCompany Overview

Headquarters
1410 Commonwealth Drive Suite 105 Wilmington, North Carolina 28403 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconFunding & Financials

  • $1M$10M

    AccuGenomics's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    AccuGenomics's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.